Renaissance Capital logo

ARQT News

Biotech SPAC Frazier Lifesciences Acquisition files for a $100 million IPO

Arcutis Biotherapeutics logo

Frazier Lifesciences Acquisition, a blank check company formed by Frazier Healthcare Partners targeting the biotech industry, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The Seattle, WA-based company plans to...read more

US IPO Week Ahead: Chinese EVs and US tax software lead a diverse 7 IPO week

VERX

Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex (VERX). A handful of companies could join the IPO calendar in the coming week, including leading mortgage lender Rocket Companies...read more

Updated: Renaissance Capital's 1Q 2020 US IPO Market Review

Arcutis Biotherapeutics logo

2020 IPO Boom Stopped Cold by Coronavirus Meltdown The 2020 IPO market began with optimism and ended with the worst crash since the global financial crisis. ...read more

Renaissance Capital's 1Q 2020 US IPO Market Review

Arcutis Biotherapeutics logo

2020 IPO Boom Stopped Cold by Coronavirus Meltdown The 2020 IPO market began with optimism and ended with the worst crash since the global financial crisis. ...read more